Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277748
Max Phase: Preclinical
Molecular Formula: C25H14N2O5S
Molecular Weight: 454.46
Associated Items:
ID: ALA5277748
Max Phase: Preclinical
Molecular Formula: C25H14N2O5S
Molecular Weight: 454.46
Associated Items:
Canonical SMILES: COc1cccc2cc(-c3csc(N4C(=O)c5cccc6cccc(c56)C4=O)n3)c(=O)oc12
Standard InChI: InChI=1S/C25H14N2O5S/c1-31-19-10-4-7-14-11-17(24(30)32-21(14)19)18-12-33-25(26-18)27-22(28)15-8-2-5-13-6-3-9-16(20(13)15)23(27)29/h2-12H,1H3
Standard InChI Key: OFDMZVNVJIMNQM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 454.46 | Molecular Weight (Monoisotopic): 454.0623 | AlogP: 4.88 | #Rotatable Bonds: 3 |
Polar Surface Area: 89.71 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.61 | CX LogD: 4.61 |
Aromatic Rings: 5 | Heavy Atoms: 33 | QED Weighted: 0.29 | Np Likeness Score: -0.76 |
1. Tomczyk MD, Walczak KZ.. (2018) l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017., 159 [PMID:30312931] [10.1016/j.ejmech.2018.09.055] |
Source(1):